Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review

Clin Lung Cancer. 2021 May;22(3):e466-e469. doi: 10.1016/j.cllc.2020.06.017. Epub 2020 Jun 19.
No abstract available

Keywords: Compound mutations; Epithelial growth factor receptor; Non–small-cell lung cancer; Osimertinib; Uncommon mutations.

Publication types

  • Case Reports